GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jinyu Bio-Technology Co Ltd (SHSE:600201) » Definitions » ROIC %

Jinyu Bio-Technology Co (SHSE:600201) ROIC % : 4.08% (As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Jinyu Bio-Technology Co ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Jinyu Bio-Technology Co's annualized return on invested capital (ROIC %) for the quarter that ended in Sep. 2024 was 4.08%.

As of today (2024-12-15), Jinyu Bio-Technology Co's WACC % is 13.27%. Jinyu Bio-Technology Co's ROIC % is 3.74% (calculated using TTM income statement data). Jinyu Bio-Technology Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Jinyu Bio-Technology Co ROIC % Historical Data

The historical data trend for Jinyu Bio-Technology Co's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinyu Bio-Technology Co ROIC % Chart

Jinyu Bio-Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.50 11.33 9.97 5.42 6.42

Jinyu Bio-Technology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.43 0.83 8.21 1.16 4.08

Competitive Comparison of Jinyu Bio-Technology Co's ROIC %

For the Biotechnology subindustry, Jinyu Bio-Technology Co's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinyu Bio-Technology Co's ROIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jinyu Bio-Technology Co's ROIC % distribution charts can be found below:

* The bar in red indicates where Jinyu Bio-Technology Co's ROIC % falls into.



Jinyu Bio-Technology Co ROIC % Calculation

Jinyu Bio-Technology Co's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=324.799 * ( 1 - 12.26% )/( (4426.093 + 4445.467)/ 2 )
=284.9786426/4435.78
=6.42 %

where

Invested Capital(A: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6389.335 - 510.87 - ( 1452.372 - max(0, 658.745 - 2680.673+1452.372))
=4426.093

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6872.582 - 677.647 - ( 1749.468 - max(0, 840.446 - 3015.892+1749.468))
=4445.467

Jinyu Bio-Technology Co's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Sep. 2024 is calculated as:

ROIC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=203.96 * ( 1 - -0.26% )/( (4982.79 + 5050.581)/ 2 )
=204.490296/5016.6855
=4.08 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6931.064 - 606.714 - ( 1341.56 - max(0, 770.53 - 2464.383+1341.56))
=4982.79

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6903.124 - 539.656 - ( 1312.887 - max(0, 693.69 - 2448.315+1312.887))
=5050.581

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinyu Bio-Technology Co  (SHSE:600201) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Jinyu Bio-Technology Co's WACC % is 13.27%. Jinyu Bio-Technology Co's ROIC % is 3.74% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Jinyu Bio-Technology Co ROIC % Related Terms

Thank you for viewing the detailed overview of Jinyu Bio-Technology Co's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinyu Bio-Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No.1, Jinyu Street, Shaeryu Industrial Park, Economic and Technological Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010030
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
Executives
Zhang Chong Yu Director
Zhang Jing Directors, senior managers
Yang Zhao senior management
Li Rong senior management
Zhang Zhan Fu Supervisors
Wei Xue Feng Director
Wang Yong Sheng Directors, senior managers
Yin Song Tao Directors, senior managers
Liu Guo Ying Supervisors
Zhang Hong Mei senior management
Wen Li Min Director
Xu Xian Ming Director
Xu Shi Jun Director
Wang Xiu Hua Director
Li Shu Jian senior management

Jinyu Bio-Technology Co Headlines

No Headlines